Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Group Inc.filedCriticalMallinckrodt Group Inc.
Priority to BG081777ApriorityCriticalpatent/BG50927A3/en
Publication of BG50927A3publicationCriticalpatent/BG50927A3/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Fodder In General
(AREA)
Abstract
The derived hormones are used for stimulating animal growth. This method averts the formation of non-soluble substances and retains the biological activity of the growth-stimulating hormone. In this way, a higher concentration of the latter in the serum is ensured.Description : the growth-regulating hormone are mixed with stabilizers representing polyols, amino acids, poly amino acids and/or choline derivatives.
BG081777A1987-11-101987-11-10A process for stabilisied growth-stimulating hormone preparation
BG50927A3
(en)
Method for stabilizing immunologically active substances immobilized on an insoluble carrier and their use in the preparation of reagents for measuring physiologically active substances
METHOD FOR PRODUCING A SOLUTION OF HIGH SPECIFIC VOLUME ACTIVITY FROM A PROTEIN WITH TISSUE PLASMINOGEN ACTIVATOR (T-PA) ACTIVITY, SOLUTION, CONTAINING PROTEIN WITH T-PA ACTIVITY AND USE OF THE SOLUTION AND IN THE HUMAN VITALIZE.
Mixed crystals of insulin and insulin derivatives, their process of manufacture, pharmaceutical agents containing them and their use in the treatment of diabetes mellitus
PROTEIN L AND ITS SUBUNITS, HAVING IMMUNOLOBULIN BINDING ACTIVITY, METHOD OF PREPARATION, REAGENT KIT, PHARMACEUTICAL PREPARATION AND A PEPTOCOCCUS MAGNUS STRAIN.